Neuropsychopharmacology
- Associations between childhood ethnoracial minority density, cortical thickness, and social engagement among minority youth at clinical high-risk for psychosis1 year ago
- Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine1 year ago
- Are novel treatments for brain disorders hiding in plain sight?1 year ago
- Closing the loop in psychiatric deep brain stimulation: physiology, psychometrics, and plasticity1 year ago
- Ventral tegmental area glutamate neurons establish a mu-opioid receptor gated circuit to mesolimbic dopamine neurons and regulate opioid-seeking behavior1 year ago
- Atypical cortical networks in children at high-genetic risk of psychiatric and neurodevelopmental disorders1 year ago
- Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice1 year ago
Journal of Psychopharmacology
- β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological–pharmacodynamic study3 years ago
- Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology3 years ago
- Individualizing tapering antipsychotic schemes considering D2 blockade dynamics3 years ago
- Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis3 years ago
- The dosing procedure that “makes the poison”: Comparing the effects of single versus cumulative alcohol administration methods on emotion recognition3 years ago
- Association study of BDNF Val66Met gene polymorphism with bipolar disorder and lithium treatment response in Indian population3 years ago
- Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction3 years ago
European Neuropsychopharmacology
- Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications2 years ago
- Lithium: What can we do to overcome the discrepancies between evidence, guideline recommendations and clinical practice?2 years ago
- Mechanisms of action of anti-bipolar drugs2 years ago
- Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA3 years ago
- Is it time to change the term negative symptoms?3 years ago
- Psychiatric disorders in Post-acute COVID-syndrome (PDPACS): Recommendations for health care professionals3 years ago
- Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. P.0877 Lithium treatment influences blood transcriptome during manic but not depressive episode in bipolar patients” [European Neuropsychopharmacology 2021 53S1. S642]3 years ago